Evidence map›Paper›PMID 26939609›Full record

ArticleBMC public health2016

Optimal waist circumference cut-off points and ability of different metabolic syndrome criteria for predicting diabetes in Japanese men and women: Japan Epidemiology Collaboration on Occupational Health Study.

Huanhuan Hu, Kayo Kurotani, Naoko Sasaki, Taizo Murakami, Chii Shimizu, Makiko Shimizu, Tohru Nakagawa, Toru Honda, Shuichiro Yamamoto, Hiroko Okazaki and 19 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMC public health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Comparison of Body Mass Index and Waist Circumference in the Prediction of Diabetes: A Retrospective Longitudinal Study.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Exercise and Depressive Disorder.Advances in experimental medicine and biology · 2020
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 13 institutions in 1 country.

Huanhuan HuDepartment of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Toyama 1-21-1, Shinjuku-ku, Tokyo, 162-8655, Japan. hu.huanhuan@yahoo.com.
Kayo KurotaniDepartment of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Toyama 1-21-1, Shinjuku-ku, Tokyo, 162-8655, Japan. kkurotani@ri.ncgm.go.jp.
Naoko SasakiMitsubishi Fuso Truck and Bus Corporation, Kanagawa, Japan. naoko.sasaki@daimler.com.
Taizo MurakamiMizue Medical Clinic, Keihin Occupational Health Center, Kanagawa, Japan. tai-murakami@jfe-steel.co.jp.
Chii ShimizuMizue Medical Clinic, Keihin Occupational Health Center, Kanagawa, Japan. ch-shimizu@jfe-steel.co.jp.
Makiko ShimizuMizue Medical Clinic, Keihin Occupational Health Center, Kanagawa, Japan. shimizu003@jfe-steel.co.jp.
Tohru NakagawaHitachi, Ltd., Ibaraki, Japan. tohru.nakagawa.rh@hitachi.com.
Toru HondaHitachi, Ltd., Ibaraki, Japan. toru.honda.kv@hitachi.com.
Shuichiro YamamotoHitachi, Ltd., Ibaraki, Japan. shuichiro.yamamoto.sr@hitachi.com.
Hiroko OkazakiMitsui Chemicals, Inc., Tokyo, Japan. hiroko2.okazaki@mitsuichemicals.com.
Satsue NagahamaAll Japan Labour Welfare Foundation, Tokyo, Japan. satsue_0323@hotmail.com.
Akihiko UeharaYAMAHA CORPORATION, Shizuoka, Japan. akihiko.uehara@music.yamaha.com.
Makoto YamamotoYAMAHA CORPORATION, Shizuoka, Japan. makoto.yamamoto@music.yamaha.com.
Kentaro TomitaMitsubishi Plastics, Inc., Tokyo, Japan. tomiken@e-mail.jp.
Teppei ImaiAzbil Corporation, Tokyo, Japan. t.imai.pz@azbil.com.
Akiko NishiharaAzbil Corporation, Tokyo, Japan. a.nishihara.d2@azbil.com.
Takeshi KochiFurukawa Electric Co., Ltd., Tokyo, Japan. mr251764@mr.furukawa.co.jp.
Masafumi EguchiFurukawa Electric Co., Ltd., Tokyo, Japan. mr252584@mr.furukawa.co.jp.
Toshiaki MiyamotoNippon Steel & Sumitomo Metal Corporation Kimitsu Works, Chiba, Japan. miyamoto.et9.toshiaki@jp.nssmc.com.
Ai HoriTokyo Gas Co., Ltd., Tokyo, Japan. horiai1115@gmail.com.
Keisuke KuwaharaDepartment of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Toyama 1-21-1, Shinjuku-ku, Tokyo, 162-8655, Japan. kuwahara@ri.ncgm.go.jp.
Shamima AkterDepartment of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Toyama 1-21-1, Shinjuku-ku, Tokyo, 162-8655, Japan. samimarub@ri.ncgm.go.jp.
Ikuko KashinoDepartment of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Toyama 1-21-1, Shinjuku-ku, Tokyo, 162-8655, Japan. kashino@ri.ncgm.go.jp.
Isamu KabeFurukawa Electric Co., Ltd., Tokyo, Japan. mr904511@mr.furukawa.co.jp.
Weiping LiuXian Janssen Pharmaceutical Ltd., Shanghai, China. liuzzz6@163.com.
Tetsuya MizoueDepartment of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Toyama 1-21-1, Shinjuku-ku, Tokyo, 162-8655, Japan. mizoue@ri.ncgm.go.jp.
Naoki KunugitaNational Institute of Public Health, Saitama, Japan. kunugita@niph.go.jp.
Seitaro DohiMitsui Chemicals, Inc., Tokyo, Japan. Seitaro.Dohi@mitsuichemicals.com.
Japan Epidemiology Collaboration on Occupational Health Study Group
National Center for Global Health and Medicine · JPFurukawa Electric (Japan) · JPHitachi (Japan) · JPKeihin (Japan) · JPAzbil (Japan) · JPMitsui Chemicals (Japan) · JPYamaha (Japan) · JPMitsubishi Fuso Truck and Bus (Japan)Mitsubishi Plastics (Japan) · JPNational Institute of Public Health · JPNippon Steel (Japan) · JPTeikyo University · JPTokyo Gas (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe sought to establish the optimal waist circumference (WC) cut-off point for predicting diabetes mellitus (DM) and to compare the predictive ability of the metabolic syndrome (MetS) criteria of the Joint Interim Statement (JIS) and the Japanese Committee of the Criteria for MetS (JCCMS) for DM in Japanese.

methodsParticipants of the Japan Epidemiology Collaboration on Occupational Health Study, who were aged 20-69 years and free of DM at baseline (n = 54,980), were followed-up for a maximum of 6 years. Time-dependent receiver operating characteristic analysis was used to determine the optimal cut-off points of WC for predicting DM. Time-dependent sensitivity, specificity, and positive and negative predictive values for the prediction of DM were compared between the JIS and JCCMS MetS criteria.

resultsDuring 234,926 person-years of follow-up, 3180 individuals developed DM. Receiver operating characteristic analysis suggested that the most suitable cut-off point of WC for predicting incident DM was 85 cm for men and 80 cm for women. MetS was associated with 3-4 times increased hazard for developing DM in men and 7-9 times in women. Of the MetS criteria tested, the JIS criteria using our proposed WC cut-off points (85 cm for men and 80 cm for women) had the highest sensitivity (54.5 % for men and 43.5 % for women) for predicting DM. The sensitivity and specificity of the JCCMS MetS criteria were ~37.7 and 98.9 %, respectively.

conclusionData from the present large cohort of workers suggest that WC cut-offs of 85 cm for men and 80 cm for women may be appropriate for predicting DM for Japanese. The JIS criteria can detect more people who later develop DM than does the JCCMS criteria.

Indexed as

Occupational HealthWaist CircumferenceAdultAgedDiabetes MellitusFemaleHumansJapanMaleMetabolic SyndromeMiddle AgedPredictive Value of TestsReference StandardsYoung Adult

Identifiers

PMID26939609
PMCPMC4778284
OpenAlexW2288689213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.